March 2025

Community Engagement & Feedback

Governmental Advisory Board (GAB) – A Key Initiative in EUCanScreen WP4

Blue and White Modern Health Screening Services Facebook Cover (22)

In an effort to gain insight into the cancer screening context within the Joint Action EUCanScreen, the various work packages have recognised the need to collect information from the consortium partners in a harmonised way across countries/regions.

 

This step is essential in guiding the next phase in implementing the planned scientific activities and ensuring the relevance of the activities and outcomes of the Joint Action within the current cancer screening ecosystem.

 

To that end, a survey coordination committee was formed with work package representatives. The committee has compiled and organised the planned questionnaires and surveys throughout the timeline of the project, grouping them according to a release schedule while ensuring coherence and complementarity.

 

The consortium has also established a collaboration with the International Agency for Research on Cancer (IARC/WHO), which is preparing for the 3rd European Cancer Screening Report (a project supported by the European Commission). Through this collaboration, information on the current landscape of cancer screening in Europe collected through EUCanScreen and IARC CanScreen-ECIS surveys will be shared and analysed jointly to achieve common goals.

 

The first phase of the surveys is launched between March and April 2025, covering a broad range of topics as detailed below:

  • WP4: Governance and sustainability of cancer screening programmes.
  • WP4 and IARC: Cancer screening landscape survey.
  • WP5: Assessment of data availability and exchange-related issues, with a particular focus on new and risk-based screening programmes.
  • WP6: Organisation of cancer screening programmes and screening for gender minorities at risk.
  • WP7: Implementation of quality assurance and patient-reported outcome measures in population-based cancer screening programmes.
  • WP7: Innovative approaches to invite target population in cancer screening programmes
  • WP9: Risk-based approaches in cancer screening.
  • WP9: Survey of communication material in risk-based screening pilot projects and programmes.
  • WP11: Assessment of the current status of training in breast cancer screening for radiologists and radiographers.

We encourage all stakeholders and consortium partners to contribute to the surveys in their respective areas of expertise upon receiving invitations. Together, we can improve the relevance of the project activities and outcomes.

Survey Coordination Group

Subscribe to our newsletter to get news and updates.

Subscribe to our newsletter to get news and updates.

Logo EU EUCanScreen Vertical

 

Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor HADEA can be held responsible for them.

tiktok

FaceBook

X

Instagram

YouTube

LinkedIn

email

EUCanScreenLogo t

The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.

FaceBook

Twitter

Instagram

YouTube

LinkedIn

Logo EU

This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959

Print Friendly, PDF & Email
Μετάβαση στο περιεχόμενο